Price T Rowe Associates Inc Bristol Myers Squibb CO Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,239,783 shares of BMY stock, worth $1.17 Billion. This represents 0.12% of its overall portfolio holdings.

Number of Shares
20,239,783
Previous 15,300,371 32.28%
Holding current value
$1.17 Billion
Previous $635 Million 64.8%
% of portfolio
0.12%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $196 Million - $256 Million
4,939,412 Added 32.28%
20,239,783 $1.05 Billion
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $111 Million - $146 Million
2,752,548 Added 21.94%
15,300,371 $635 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $262 Million - $297 Million
5,461,767 Added 77.08%
12,547,823 $680 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $19.5 Million - $23.2 Million
401,783 Added 6.01%
7,086,056 $364 Million
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $32.1 Million - $35.9 Million
554,532 Added 9.05%
6,684,273 $388 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $55.9 Million - $62.1 Million
-878,078 Reduced 12.53%
6,129,741 $392 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $25.6 Million - $29 Million
-389,635 Reduced 5.27%
7,007,819 $486 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $89.8 Million - $106 Million
1,311,960 Added 21.56%
7,397,454 $532 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $1.11 Million - $653 Million
-8,501,529 Reduced 58.28%
6,085,494 $433 Million
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $88.3 Million - $97.3 Million
-1,216,245 Reduced 7.7%
14,587,023 $1.12 Billion
Q1 2022

May 16, 2022
BUY
$61.48 - $73.72 $765 Million - $917 Million
12,445,264 Added 370.61%
15,803,268 $1.15 Billion
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $29 Million - $33.8 Million
-541,195 Reduced 13.88%
3,358,004 $209 Million
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $19.3 Million - $22.6 Million
325,660 Added 9.11%
3,899,199 $231 Million
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $3.46 Million - $3.77 Million
-55,905 Reduced 1.54%
3,573,539 $239 Million
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $18.1 Million - $20.4 Million
-305,655 Reduced 7.77%
3,629,444 $229 Million
Q4 2020

Feb 16, 2021
BUY
$57.74 - $65.43 $227 Million - $257 Million
3,935,099 New
3,935,099 $244 Million

Others Institutions Holding BMY

# of Institutions
2,532
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email